Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· TPC Research

Rapamycin and the Biology of Aging #peptideresearch #science #peptides #biohacking

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original language

Rapamycin is not a proven human longevity therapy. But it has become one of the most consequential molecules in aging biology because of what it has repeatedly done in the laboratory. Rapamycin targets mTOR, the mechanistic target of rapamycin: a nutrient-sensing kinase that integrates amino acids, growth factors, energy status, and cellular stress. When mTORC1 is active, it promotes anabolic growth, protein synthesis, and cell proliferation. It also suppresses autophagy—the cellular process that dismantles and recycles damaged proteins and dysfunctional organelles. By inhibiting mTORC1, rapamycin shifts the cell from constant construction toward maintenance. Protein synthesis is reduced, autophagic recycling is released, and proteostasis is reinforced. This is why mTOR sits at the intersection of so many longevity pathways: nutrient sensing, mitochondrial quality control, cellular senescence, and autophagy. The lifespan evidence is unusually strong for preclinical research. Genetic suppression of TOR signaling extended lifespan in yeast, nematodes, and fruit flies. Rapamycin then extended lifespan in multiple mouse experiments, including genetically heterogeneous mice studied at three independent sites. In one dose study, median lifespan rose by 23% in male mice and 26% in female mice at the highest tested dose. But scientific precision matters. This is not proof that rapamycin extends human lifespan. Results vary with species, strain, sex, dose, and timing. Chronic mTOR inhibition can also affect immune signaling, glucose regulation, and lipid metabolism. The significance of rapamycin is not that aging has been solved; it is that mTOR has emerged as one of the deepest, most reproducible control systems in aging research. (Educational purposes only. Not medical advice. For research literacy and optimization science.) #Rapamycin #mTOR #LongevityResearch #Autophagy #CellularBiology #AgingScience #Proteostasis #Mitochondria #Geroprotection #MedicalScience #biochemistry

TPC Research · 2 min · Source published: 2026-08-13

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…